<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Genomics</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Genomics</journal-id>
    <journal-title-group>
      <journal-title>BMC Genomics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2164</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">7227348</article-id>
    <article-id pub-id-type="publisher-id">6744</article-id>
    <article-id pub-id-type="doi">10.1186/s12864-020-6744-4</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Software</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>An integrated software for virus community sequencing data analysis</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" equal-contrib="yes">
        <name>
          <surname>Wang</surname>
          <given-names>Mingjie</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author" equal-contrib="yes">
        <name>
          <surname>Li</surname>
          <given-names>Jianfeng</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Xiaonan</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Han</surname>
          <given-names>Yue</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yu</surname>
          <given-names>Demin</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Donghua</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yuan</surname>
          <given-names>Zhenghong</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Yang</surname>
          <given-names>Zhitao</given-names>
        </name>
        <address>
          <email>yangzhitao@hotmail.fr</email>
        </address>
        <xref ref-type="aff" rid="Aff4">4</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Huang</surname>
          <given-names>Jinyan</given-names>
        </name>
        <address>
          <email>jinyan@shsmu.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0598-6425</contrib-id>
        <name>
          <surname>Zhang</surname>
          <given-names>Xinxin</given-names>
        </name>
        <address>
          <email>zhangx@shsmu.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff5">5</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.16821.3c</institution-id><institution-id institution-id-type="ISNI">0000 0004 0368 8293</institution-id><institution>Research Laboratory of Clinical Virology, Ruijin Hospital, </institution><institution>Shanghai Jiaotong University, School of Medicine, </institution></institution-wrap>Shanghai, 200025 China </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.16821.3c</institution-id><institution-id institution-id-type="ISNI">0000 0004 0368 8293</institution-id><institution>State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital, </institution><institution>Shanghai Jiaotong University School of Medicine, </institution></institution-wrap>Shanghai, 200025 China </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.8547.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 0125 2443</institution-id><institution>Key Lab of Medicine Molecular Virology of MOE/MOH, Shanghai Medical School, </institution><institution>Fudan University, </institution></institution-wrap>Shanghai, 200032 China </aff>
      <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.16821.3c</institution-id><institution-id institution-id-type="ISNI">0000 0004 0368 8293</institution-id><institution>Emergency Department, Ruijin Hospital, </institution><institution>Shanghai Jiaotong University, School of Medicine, </institution></institution-wrap>Shanghai, 200025 China </aff>
      <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.16821.3c</institution-id><institution-id institution-id-type="ISNI">0000 0004 0368 8293</institution-id><institution>Clinical Research Center, Ruijin Hospital North, </institution><institution>Shanghai Jiaotong University, School of Medicine, </institution></institution-wrap>Shanghai, 201821 China </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>15</day>
      <month>5</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>15</day>
      <month>5</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2020</year>
    </pub-date>
    <volume>21</volume>
    <elocation-id>363</elocation-id>
    <history>
      <date date-type="received">
        <day>12</day>
        <month>2</month>
        <year>2020</year>
      </date>
      <date date-type="accepted">
        <day>21</day>
        <month>4</month>
        <year>2020</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s). 2020</copyright-statement>
      <license license-type="OpenAccess">
        <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">A virus community is the spectrum of viral strains populating an infected host, which plays a key role in pathogenesis and therapy response in viral infectious diseases. However automatic and dedicated pipeline for interpreting virus community sequencing data has not been developed yet.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par2">We developed Quasispecies Analysis Package (QAP), an integrated software platform to address the problems associated with making biological interpretations from massive viral population sequencing data. QAP provides quantitative insight into virus ecology by first introducing the definition “virus OTU” and supports a wide range of viral community analyses and results visualizations. Various forms of QAP were developed in consideration of broader users, including a command line, a graphical user interface and a web server. Utilities of QAP were thoroughly evaluated with high-throughput sequencing data from hepatitis B virus, hepatitis C virus, influenza virus and human immunodeficiency virus, and the results showed highly accurate viral quasispecies characteristics related to biological phenotypes.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p id="Par3">QAP provides a complete solution for virus community high throughput sequencing data analysis, and it would facilitate the easy analysis of virus quasispecies in clinical applications.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Virus community</kwd>
      <kwd>High throughput sequencing</kwd>
      <kwd>Pipeline</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id>
            <institution>National Natural Science Foundation of China</institution>
          </institution-wrap>
        </funding-source>
        <award-id>81672069</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Major National Projects for Infectious Diseases</institution>
        </funding-source>
        <award-id>2017ZX10202202</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>National Key Research and Development Program</institution>
        </funding-source>
        <award-id>2016YFC0902800</award-id>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2020</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par25">Viral infections are major global public health issues and cause a high mortality rate every year worldwide. Due to the high genomic variability of RNA viruses and some DNA viruses, a massive, complex and dynamic distribution of variants, termed a viral quasispecies (QS), is generated during replication in viral infections [<xref ref-type="bibr" rid="CR1">1</xref>]. Genetic interactions between heterogeneous mutant virus strains within a quasispecies have been proposed to affect the overall fitness of the population through a combination of cooperative and antagonistic effects, conferring high adaptability under selective pressure in changing environments, especially under the host immune response and antiviral drugs, causing immune escape and drug resistance [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>].</p>
    <p id="Par26">Remarkable advances in DNA sequencing technologies have enabled the comprehensive assessment of virus variability and quasispecies signatures, including the rapid evolution of next-generation sequencing (NGS) and the emergence of third-generation sequencing (TGS) [<xref ref-type="bibr" rid="CR4">4</xref>–<xref ref-type="bibr" rid="CR6">6</xref>]. In addition, novel sequencing strategies [<xref ref-type="bibr" rid="CR6">6</xref>] and algorithms for virus haplotype reconstruction [<xref ref-type="bibr" rid="CR7">7</xref>–<xref ref-type="bibr" rid="CR10">10</xref>] are making high-throughput sequencing (HTS) preferable for quasispecies detection. Massive amounts of data have been generated, providing unprecedented opportunities to address fundamental questions in virology. However, computer-assisted technologies to determine population structure or biological functions of viruses remain a neglected area. The application of bioinformatics to this field is currently unsatisfying with respect to its medical and biological importance [<xref ref-type="bibr" rid="CR11">11</xref>]. There are no existing tools providing a complete pipeline for quasispecies HTS data analysis and quasispecies population characteristics. Hence, an integrated and automatic software for the characterization of viral quasispecies could be of great interest for time-effective, full exploitation of quasispecies HTS data.</p>
    <p id="Par27">Viral infectious diseases include many different clinical conditions that are often not well recognized and characterized by conventional imagological and biochemical tests. Many studies have demonstrated that a viral population is highly associated with clinical manifestations and treatment responses [<xref ref-type="bibr" rid="CR12">12</xref>–<xref ref-type="bibr" rid="CR16">16</xref>]. Discovering biomarkers from viral quasispecies that could precisely reflect infection status has always been a pressing issue for clinicians. Therefore, discovering novel quantitative indexes to monitor virological changes is quite necessary. Reliable software with an easy-to-use interface and legible reports for viral quasispecies quantification may help with patient diagnosis, therapy, and management and eventually lead to promising advances in precision medicine in viral infectious diseases.</p>
    <p id="Par28">Here, we present QAP, an integrated quasispecies analysis package, designed with a command line utility, local graphical user interface (GUI) and cloud computation service for automatic virus quasispecies analysis. The key originality of QAP lies in not only the integrity and completeness of the analysis tools it provides but also the novel methods for quasispecies characterization and quantification. In QAP, tools for viral population quantification were developed, which provide deeper insight into quasispecies composition and a new strategy to study associations between viral populations and clinical features. QAP is freely available as a local application and as a web service to be user-friendly for bioinformatics scientists, virologists and clinicians.</p>
  </sec>
  <sec id="Sec2">
    <title>Implementation</title>
    <p id="Par29">QAP is developed in Perl, R and Java and totally 41 tools were developed and categorized into 6 modules based on their functionality: (1) Data preprocessing module, (2) Sequence manipulation module, (3) Quasispecies characterization module, (4) Quantification and multiple samples comparisons module, (5) Useful tools module, and (6) Visualization module. An overview of all tools in QAP and their corresponding inputs and outputs are depicted in Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S1, and the whole structure of the QAP pipeline is shown in Fig. <xref rid="Fig1" ref-type="fig">1</xref>. The QAP interface is facilitated through a user-friendly wrapper script, from which all tools and documentations can be invoked (Addition file <xref rid="MOESM3" ref-type="media">3</xref>: Fig. S1). Detailed information about each tool is available in Additional file <xref rid="MOESM1" ref-type="media">1</xref>.
<fig id="Fig1"><label>Fig. 1</label><caption><p>Schematic overview of tools and pipelines in QAP. Cylinders represent data files, while rhombuses represent condition statements. Rectangles represent tools in QAP, and tools in different categories are highlighted with different colours. Arrows indicate the flow between the data file, tools and condition statements</p></caption><graphic xlink:href="12864_2020_6744_Fig1_HTML" id="MO1"/></fig></p>
    <p id="Par30">QAP was designed to handle different kinds of sequencing data: (1) for amplicon NGS data, the tool <italic>AssembleSeq</italic> screens and assembles read pairs based on mapping details; (2) for shotgun NGS data, the tool <italic>ECnQSR</italic> includes 5 published algorithms including SAVAGE [<xref ref-type="bibr" rid="CR17">17</xref>], ShoRAH [<xref ref-type="bibr" rid="CR7">7</xref>], PredictHaplo [<xref ref-type="bibr" rid="CR9">9</xref>], ViQuaS [<xref ref-type="bibr" rid="CR10">10</xref>], and QuRe [<xref ref-type="bibr" rid="CR8">8</xref>] to reconstruct viral haplotypes; and (3) for TGS reads, a “2-pass mapping” algorithm was developed to reads raw CCS reads generated by PacBio sequencers and processes them into aligned viral haplotypes in the tool <italic>TGSpipeline</italic>. The whole processing scheme of <italic>TGSpipeline</italic> is shown in Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Fig. S2.</p>
    <p id="Par31">The aim of QS sequencing is to determine the precise virus spectrum, and the mapping and alignment of viral haplotype sequences should be highly accurate. Tool <italic>FixCircRef</italic> were designed to locate the mapping region for circular viral genomes and generate a fixed reference sequence to avoid junction mapping reads (Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Fig. S3). Several frequently used programs for both global and local multiple sequence alignments are included in the tool <italic>MultipleSeqAlign</italic>, including Clustal W version 2.0 [<xref ref-type="bibr" rid="CR18">18</xref>], MUSCLE [<xref ref-type="bibr" rid="CR19">19</xref>] and Clustal Omega [<xref ref-type="bibr" rid="CR20">20</xref>].</p>
    <p id="Par32">Quasispecies complexity is usually measured using normalized Shannon entropy Efficiency (Sn) according to following formula: Sn = <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ -\sum \limits_i\left({p}_i\mathit{\ln}\ {p}_i\right)/ lnN $$\end{document}</tex-math><mml:math id="M2" display="inline"><mml:mo>−</mml:mo><mml:munder><mml:mo>∑</mml:mo><mml:mi>i</mml:mi></mml:munder><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo mathvariant="italic">ln</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>/</mml:mo><mml:mi mathvariant="italic">lnN</mml:mi></mml:math><inline-graphic xlink:href="12864_2020_6744_Article_IEq1.gif"/></alternatives></inline-formula> [<xref ref-type="bibr" rid="CR21">21</xref>], where <italic>p</italic><sub><italic>i</italic></sub> represents the frequency of each type of strain in the quasispecies population, and <italic>N</italic> corresponds to the sequencing depth. In the tool <italic>ShannonEntropy</italic>, two methods were developed to remove bias introduced by sequencing depth: (1) use Shannon entropy instead with following formula: Sn = <inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ -\sum \limits_i\left({p}_i\mathit{\ln}\ {p}_i\right) $$\end{document}</tex-math><mml:math id="M4" display="inline"><mml:mo>−</mml:mo><mml:munder><mml:mo>∑</mml:mo><mml:mi>i</mml:mi></mml:munder><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo mathvariant="italic">ln</mml:mo><mml:mspace width="0.25em"/><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mfenced></mml:math><inline-graphic xlink:href="12864_2020_6744_Article_IEq2.gif"/></alternatives></inline-formula>, and (2) use a multiplicating random down sampling method to select a subpopulation of given size. Variation detection is crucial for quasispecies characterization. Thus, two tools <italic>MutationCaller</italic> and <italic>MSAMutationCaller</italic> were developed based on published software, including GATK [<xref ref-type="bibr" rid="CR22">22</xref>], VarScan2 [<xref ref-type="bibr" rid="CR23">23</xref>] and LoFreq [<xref ref-type="bibr" rid="CR24">24</xref>]. Demonstration for software output were shown in Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S2.</p>
    <p id="Par33">The MFI (Mutation frequency index) value is calculated based on the following formula: MFI = <italic>N</italic> / (<italic>L</italic> × <italic>D</italic>) [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR25">25</xref>], where <italic>N</italic> represents the total number of variations detected, <italic>L</italic> represents the length of the amplicons and <italic>D</italic> represents the sequencing depth. Based on viral genomic mutations, the tool MFI can subsequently identify and visualize “hot regions” with high mutation frequencies (Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Fig. S4A). Consensus sequences of quasispecies can be calculated by using the tool <italic>ConsensusSeq</italic>, which concatenates the bases with the highest frequencies at each position and provides a graphical representation of significant patterns by using WebLogo [<xref ref-type="bibr" rid="CR26">26</xref>]. (Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Fig. S4B). The tool <italic>DominantStrain</italic> calculates the proportions of different viral haplotypes and regards the highest one as the dominant strain (Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Fig. S4C).</p>
    <p id="Par34">In order to define a unified quantitative unit, the concept of “operational taxonomic unit (OTU)” was borrowed from bacteria metagenomics analysis and re-defined here as viral strains with high homology. The tools PickRobustOTU and PickClusterOTU could define and pick viral OTUs based on sequence count (<italic>C</italic>) and quantity OTUs using the formula <inline-formula id="IEq3"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\mathit{\log}}_2\left(\frac{C}{N}M+1\right) $$\end{document}</tex-math><mml:math id="M6" display="inline"><mml:msub><mml:mo mathvariant="italic">log</mml:mo><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=")" open="("><mml:mrow><mml:mfrac><mml:mi>C</mml:mi><mml:mi>N</mml:mi></mml:mfrac><mml:mi>M</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced></mml:math><inline-graphic xlink:href="12864_2020_6744_Article_IEq3.gif"/></alternatives></inline-formula>, where <italic>C</italic> represents the sequence count of a specific OTU, <italic>N</italic> represents the total number of sequences, and <italic>M</italic> represents a multiplier coefficient that corrects the minimum <inline-formula id="IEq4"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \frac{C}{N} $$\end{document}</tex-math><mml:math id="M8" display="inline"><mml:mfrac><mml:mi>C</mml:mi><mml:mi>N</mml:mi></mml:mfrac></mml:math><inline-graphic xlink:href="12864_2020_6744_Article_IEq4.gif"/></alternatives></inline-formula> into a positive float more than 1. OTU abundance matrix were then normalized by using R package preprocessCore. The workflows of <italic>PickRobustOTU</italic> and <italic>PickClusterOTU</italic> are shown in Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Fig. S5.</p>
    <sec id="Sec3">
      <title>Cloud computation platform</title>
      <p id="Par35">We developed a web-based computation platform for QAP, named wQAP. wQAP was built on top of Galaxy [<xref ref-type="bibr" rid="CR27">27</xref>] which was constructed by using Django framework.</p>
      <p id="Par36">When using wQAP, raw data will be added to the user history and processed by analysis modules step-by-step (Fig. <xref rid="Fig2" ref-type="fig">2</xref>a). As shown in Fig. <xref rid="Fig2" ref-type="fig">2</xref>b, c, all tools can be easily accessed from the main page, including both QAP tools and tools embedded in Galaxy. To support the Workflow Management System of Galaxy, tools in wQAP are also designed with optimized input and output format, which could be easily connected and constitute customized pipelines.
<fig id="Fig2"><label>Fig. 2</label><caption><p>Workflow and screenshots of wQAP. <bold>a</bold> Workflow of wQAP. Coloured rectangles correspond to six tool categories. Lines represent data files, including input sequencing reads, viral haplotypes and viral genes. Arrows indicate the flow between inputs, processes and outputs. <bold>b</bold> Screenshot showing the main page of wQAP. <bold>c</bold>, Screenshot showing usage of the tool <italic>RawDataFiltration</italic></p></caption><graphic xlink:href="12864_2020_6744_Fig2_HTML" id="MO2"/></fig></p>
    </sec>
    <sec id="Sec4">
      <title>Local graphic user interface</title>
      <p id="Par37">The QAP GUI is implemented in Java as a desktop application which could be activated by using “qap –g” in command line. Screenshots of the QAP main interface and pipeline construction interface are shown in Fig. <xref rid="Fig3" ref-type="fig">3</xref>a, b. The GUI application generates a JSON file to save the customized pipeline structure and an executable shell script for direct usage (Fig. <xref rid="Fig3" ref-type="fig">3</xref>c). As shown in Fig. <xref rid="Fig3" ref-type="fig">3</xref>d, arguments can be provided through text fields or drop-down lists. After checking the validity of arguments, the program will start running and representing output information (Fig. <xref rid="Fig3" ref-type="fig">3</xref>e).
<fig id="Fig3"><label>Fig. 3</label><caption><p>Schematic overview of pipeline construction and screenshots of the QAP GUI. <bold>a</bold> Screenshot of the QAP GUI main interface. <bold>b</bold> Screenshot showing the pipeline construction interface. <bold>c</bold> Screenshot showing the pipeline Shell script generated. <bold>d</bold> Screenshot of the argument input interface. <bold>e</bold> Screenshot of the program running interface</p></caption><graphic xlink:href="12864_2020_6744_Fig3_HTML" id="MO3"/></fig></p>
    </sec>
  </sec>
  <sec id="Sec5">
    <title>Results</title>
    <p id="Par38">A broad range of tools were developed in QAP for users to analyse data from different angles and build customized pipelines. Below, we evaluate the utilities of QAP using different kinds of virus community sequencing data.</p>
    <sec id="Sec6">
      <title>Comprehensive evaluation using HBV quasispecies sequencing data</title>
      <p id="Par39">To assess the advantages of integrated analysis tools in QAP, comprehensive data sets of HBV QS were used, including clone-based sequencing (CBS), NGS and TGS data. Datasets details were described in Additional file <xref rid="MOESM1" ref-type="media">1</xref>, and amplification details for HBV NGS data were also illustrated in Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S3, and Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Fig. S6.</p>
      <p id="Par40">As CBS is considered the “gold standard” in quasispecies detection [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>], paired TGS and CBS data derived from 10 HBV-infected patients were analysed to measure the accuracy of QAP in TGS data processing. Bland-Altman approach was carried out to compare the quasispecies heterogeneities of 4 viral ORFs (C, P, S and X) derived from TGS and CBS, and the result indicated a high level of agreement (Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Fig. S7).</p>
      <p id="Par41">To further explore the functionality and clinical significance of QAP tools, a retrospective cohort study analysing an HBV whole-genome quasispecies was carried out. Clinical features of all patients are summarized in Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S4. Hierarchical clustering analysis was carried out to explore the correlations between viral populations and clinical phenotypes. Notably, the dendrogram of patients generated by OTUHeatmap showed significant clusters (subgroups G1-G6) correlated to infection phases (Fig. <xref rid="Fig4" ref-type="fig">4</xref>a, <italic>P</italic> = 2.20 × 10<sup>− 16</sup>), and PCA carried out by SamplePCA showed similar results (Fig. <xref rid="Fig4" ref-type="fig">4</xref>b, <italic>P</italic> = 1.35 × 10<sup>− 13</sup>). Furthermore, sample clustering and the top 3 principle components all showed significant correlations with patients’ clinical traits (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S5). Viral spectrum structures of different samples were also explored by using OTUBarplot (Fig. <xref rid="Fig4" ref-type="fig">4</xref>c), and distinct components were discovered. Correlations among different samples were also analysed by using SampleCorrelation (Fig. <xref rid="Fig4" ref-type="fig">4</xref>d). A network among different samples and OTUs was constructed, and significant OTUs were highlighted (Fig. <xref rid="Fig4" ref-type="fig">4</xref>e). Phylogenetic analysis was also carried out based on OTU sequences (Fig. <xref rid="Fig4" ref-type="fig">4</xref>f).
<fig id="Fig4"><label>Fig. 4</label><caption><p>Example outputs from QAP analysis of NGS of HBV QS data. <bold>a</bold> Hierarchical clustering of samples and OTUs. Representative OTUs corresponding to ACLF patients are highlighted with red lines. <bold>b</bold> Scatter plot showing the PCA results. <bold>c</bold> Bar plots showing OTU abundances. <bold>d</bold> Heat map showing sample correlations. <bold>e</bold> Network showing correlations between samples and OTUs. Node size and colour correspond to OTU abundance and sample weight. <bold>f</bold> Phylogenetic tree showing OTU homology; font size and colour corresponds to OTU abundance</p></caption><graphic xlink:href="12864_2020_6744_Fig4_HTML" id="MO4"/></fig></p>
    </sec>
    <sec id="Sec7">
      <title>Evaluations using various viral community sequencing data</title>
      <p id="Par42">QAP utilities were further tested on different viruses, including HCV, H7N9 and HIV and simulated data of HBV. Shot-gun sequencing data of HCV was derived from the study of Babcock G.J. et al. [<xref ref-type="bibr" rid="CR30">30</xref>], in which HCV E2 region of 6 antibody (MBL-HCV1)-treated subjects and 5 placebo-treated subjects were sequenced. Mutations in all subjects were identified, and showed consistent results with previous study (Fig. <xref rid="Fig5" ref-type="fig">5</xref>a, Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S6) [<xref ref-type="bibr" rid="CR30">30</xref>].
<fig id="Fig5"><label>Fig. 5</label><caption><p>Outputs from QAP analysis of HCV,H7N9 and HIV QS data. <bold>a</bold> Hierarchical clustering of mutation sites in the HCV E2 region. <bold>b</bold> Circos plot of mutations in two H7N9 strains. The outside track corresponds to 8 segments of the viral genome. Tracks in the light grey (dark grey) background colour correspond to strain 5109 (5083) treated with 10 μM, 20 μM, 100 μM, 200 μM and 500 μM oseltamivir. Green (blue) dots represent variations in strain 5109 (5083), and dot size corresponds to mutation frequencies. <bold>c</bold> Frequencies of mutation sites between pNL4.3 and p89.6 in the mixtures V01 and V02. Bar height corresponds to base abundance. The true ratios are marked with black lines. <bold>d</bold> Half violin plot of abundances of HBV genotype C viral strain in simulation data sets. The true ratios are marked with blue lines</p></caption><graphic xlink:href="12864_2020_6744_Fig5_HTML" id="MO5"/></fig></p>
      <p id="Par43">Two human H7N9 strains (5190, 5083), which were isolated from two infected patients [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>], were cultured in ascending concentrations of oseltamivir carboxylate with the help of exogenous neuraminidase to induce oseltamivir resistance mutations. Details for H7N9 amplification were described in additional file <xref rid="MOESM1" ref-type="media">1</xref> and additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S7. The results showed that frequencies of the drug resistance mutation Q226L and R292K elevated gradually with increasing concentrations of oseltamivir carboxylate. (Fig. <xref rid="Fig5" ref-type="fig">5</xref>b). Amplicon sequencing data from mixtures of two HIV plasmids were retrieved from the NCBI SRA database. Mixture V01 consisted of 50% plasmid pNL4.3 and 50% p89.6, while mixture V02 consisted of 10% pNL4.3 and 90% p89.6. The abundance of viral strains were highly consistent with mixing proportions (Fig. <xref rid="Fig5" ref-type="fig">5</xref>c). All of these results confirmed the effectiveness and practicability of QAP in viral community sequencing data analysis. We further evaluated the performance of QAP with two groups of simulation data sets which were generated with pre-defined abundances of viral strains, and the result also showed high consistency between observed values and true values (Fig. <xref rid="Fig5" ref-type="fig">5</xref>d).</p>
    </sec>
    <sec id="Sec8">
      <title>Comparison of QAP with existing tools</title>
      <p id="Par44">We compared QAP with several existing software platforms, including SAVAGE [<xref ref-type="bibr" rid="CR17">17</xref>], ShoRAH [<xref ref-type="bibr" rid="CR7">7</xref>], PredictHaplo [<xref ref-type="bibr" rid="CR9">9</xref>], QuRe [<xref ref-type="bibr" rid="CR8">8</xref>] and ViQuaS [<xref ref-type="bibr" rid="CR10">10</xref>], to investigate their calculation performances. All software was tested using HBV TGS and NGS data, and QAP and ViQuaS demonstrated the best time efficiency when testing NGS data, while QuRe was the most time-consuming, which was consistent with published results [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. A summary of the specialties of QAP and other existing software were shown in Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S8.</p>
    </sec>
    <sec id="Sec9">
      <title>Clinical applications of QAP quantitative methods</title>
      <p id="Par45">The clinical applications of OTU quantification were further evaluated in chronically HBV-infected patients, including LC patients and non-liver cirrhosis (NLC) patients. To build diagnostic models for LC patients based on viral population quantification, both LC and NLC patients were randomly and equally divided into training groups and validation groups. Three diagnostic models were built by using machine learning methods, including support vector machine (SVM), K-nearest neighbour (KNN), and random forest (RF), based on viral strain abundances of patients in training groups. The performances of all models were then evaluated and compared to the commonly used clinical parameters APRI and FIB-4 in validation groups. The results showed that the SVM model had the highest accuracy for LC patient diagnosis with an AUROC (area under receiver operating characteristic curve) value equal to 1.00 (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S9, Fig. <xref rid="Fig6" ref-type="fig">6</xref>a, b, c).
<fig id="Fig6"><label>Fig. 6</label><caption><p>Performance of novel diagnostic and predictive models based on QS quantification. <bold>a</bold>-<bold>c</bold> Receiver operating characteristic (ROC) curves of LC diagnostic models, including SVM, KNN and RF models. <bold>d</bold>-<bold>e</bold> Sn and d between QS of responders and non-responders. <bold>f</bold> PCA of QS of responders and non-responders. <bold>g</bold> ROC curves of PC1 compared with Sn and d</p></caption><graphic xlink:href="12864_2020_6744_Fig6_HTML" id="MO6"/></fig></p>
      <p id="Par46">Quasispecies between 10 antiviral therapy responders and 10 non-responders were compared at treatment baseline. QS heterogeneities, including Sn and mean genetic distance (d), both showed no significant difference between two kinds of patients (Fig. <xref rid="Fig6" ref-type="fig">6</xref>d, e). However, by using QAP quantification methods, PCA of QS showed significantly separated clusters, and principle component 1 (PC1) was significantly related to treatment outcomes (<italic>P</italic> = 2.61 × 10<sup>− 15</sup>) (Fig. <xref rid="Fig6" ref-type="fig">6</xref>f), which showed superior performance in distinguishing responders and non-responders relative to general quasispecies heterogeneities (Fig. <xref rid="Fig6" ref-type="fig">6</xref>g).</p>
    </sec>
  </sec>
  <sec id="Sec10">
    <title>Discussion</title>
    <p id="Par47">Viral haplotype determination is the key step in virus community data analysis. There are several possible approaches for determining virus haplotypes: (1) pair-ended amplicon sequencing with relative long read length [<xref ref-type="bibr" rid="CR34">34</xref>]; (2) quasispecies reconstruction based on shotgun sequencing [<xref ref-type="bibr" rid="CR7">7</xref>–<xref ref-type="bibr" rid="CR10">10</xref>]; (3) single molecule sequencing platforms, such as PacBio [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR35">35</xref>] and Nanopore; and (4) barcode-tagged refined sequencing methods [<xref ref-type="bibr" rid="CR6">6</xref>]. QAP is the first all-in-one software for virus community data analysis that meets the requirements for various sequencing platforms and strategies.</p>
    <p id="Par48">The key innovation of QAP is the development of viral OTU quantitative methods, which allow exploration of a new field for virology research. In chronically HBV-infected patients, the early diagnosis of liver cirrhosis is crucial for making treatment decisions. Here, we preliminarily studied the clinical usage of QAP and built diagnostic models based on viral OTU quantification. Thus, QAP might promote the application of quasispecies in clinical practice and shed light on precise diagnosis in countless virus-infected patients.</p>
    <p id="Par49">Recently, Docker has received increasing attention throughout the bioinformatics community. A Docker image with QAP and all dependencies was developed, allowing the straightforward use of QAP on any operating system. Thus, totally four distribution forms of QAP are provided to meet the needs of different users: a command line program, a Galaxy-based web server, a GUI program and a Docker image.</p>
  </sec>
  <sec id="Sec11">
    <title>Conclusions</title>
    <p id="Par50">we present QAP, an integrated application and web service for virus community sequencing data analysis. QAP allows comprehensive and rapid characterization of quasispecies from different platforms and sequencing strategies, which have been demonstrated using HBV, HCV, HIV and H7N9-related viral community studies. In addition, QAP was first implemented for quasispecies quantification among multiple samples, facilitating the discovery of important correlations between the virus spectrum and clinical phenotypes in HBV-infected patients, showing great potential in patient diagnosis and prognosis prediction. The QAP web application and local GUI facilitate the easy analysis of virus quasispecies by clinicians and other laboratories. We expect that QAP will be a starting point for researchers to dive more deeply into computational analysis in relevant fields, and finally accelerate the application of quasispecies in routine clinical tests in the future.</p>
  </sec>
  <sec id="Sec12">
    <title>Availability and requirements</title>
    <p id="Par51">
      <list list-type="bullet">
        <list-item>
          <p id="Par52">Project name: QAP</p>
        </list-item>
        <list-item>
          <p id="Par53">Project home page: <ext-link ext-link-type="uri" xlink:href="http://life2cloud.com:6005/qap">http://life2cloud.com:6005/qap</ext-link></p>
        </list-item>
        <list-item>
          <p id="Par54">Operating system(s): Platform-independent</p>
        </list-item>
        <list-item>
          <p id="Par55">Programming language: Perl, R, Java</p>
        </list-item>
        <list-item>
          <p id="Par56">License: All software and scripts are licensed under GPLv3.</p>
        </list-item>
      </list>
    </p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary information</title>
    <sec id="Sec13">
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="12864_2020_6744_MOESM1_ESM.docx">
            <caption>
              <p><bold>Additional file 1 Supplementary Methods.</bold> Detailed methods for pipeline implementation and generation of data for software evaluations.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM2">
          <media xlink:href="12864_2020_6744_MOESM2_ESM.xlsx">
            <caption>
              <p><bold>Additional file 2 Table S1.</bold> An overview of tools in QAP. <bold>Table S2.</bold> Demonstration of outputs of tools <italic>MutationCaller</italic> and <italic>MSAMutationCaller</italic>. <bold>Table S3.</bold> Forward and reverse primers for HBV genome amplification. <bold>Table S4.</bold> Characterizations of clinical features of HBV infected patients. <bold>Table S5.</bold> Statistical significance of associations between sample subgroups/principle components and clinical traits. <bold>Table S6.</bold> Drug resistance associated mutations of all subjects in HCV shot-gun sequencing data analysis. <bold>Table S7.</bold> Forward and reverse primers for H7N9 genome amplification. <bold>Table S8.</bold> Overview comparison of QAP and existing software. <bold>Table S9.</bold> Performance of LC diagnostic models and clinical parameters.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM3">
          <media xlink:href="12864_2020_6744_MOESM3_ESM.docx">
            <caption>
              <p><bold>Additional file 3 Figure. S1.</bold> Screenshot of the QAP main program in command line. <bold>Figure S2.</bold> Schematic overview of the tool <italic>TGSpipeline</italic>. <bold>Figure S3.</bold> Schematic overview of the tool <italic>FixCircRef</italic>. <bold>Figure S4.</bold> Example results generated by QAP. <bold>Figure S5.</bold> Schematic overview of OTU picking. <bold>Figure S6.</bold> Example results generated by Circos and IGV tools showing the amplicons of HBV whole-genome sequencing. <bold>Figure S7.</bold> Bland-Altman analysis of heterogeneity of 4 ORFs in TGS data compared with CBS data.</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>ACLF</term>
        <def>
          <p id="Par4">Acute-on-chronic liver failure</p>
        </def>
      </def-item>
      <def-item>
        <term>AHB</term>
        <def>
          <p id="Par5">Acute hepatitis B</p>
        </def>
      </def-item>
      <def-item>
        <term>CBS</term>
        <def>
          <p id="Par6">Clone-based sequencing</p>
        </def>
      </def-item>
      <def-item>
        <term>CHB</term>
        <def>
          <p id="Par7">Chronic hepatitis B</p>
        </def>
      </def-item>
      <def-item>
        <term>GUI</term>
        <def>
          <p id="Par8">Local graphical user interface</p>
        </def>
      </def-item>
      <def-item>
        <term>HTS</term>
        <def>
          <p id="Par9">High-throughput sequencing</p>
        </def>
      </def-item>
      <def-item>
        <term>IT</term>
        <def>
          <p id="Par10">Immune tolerance</p>
        </def>
      </def-item>
      <def-item>
        <term>KNN</term>
        <def>
          <p id="Par11">K-nearest neighbour</p>
        </def>
      </def-item>
      <def-item>
        <term>LC</term>
        <def>
          <p id="Par12">Liver cirrohosis</p>
        </def>
      </def-item>
      <def-item>
        <term>MFI</term>
        <def>
          <p id="Par13">Mutation frequency index</p>
        </def>
      </def-item>
      <def-item>
        <term>MSA</term>
        <def>
          <p id="Par14">Multiple sequences alignment</p>
        </def>
      </def-item>
      <def-item>
        <term>NGS</term>
        <def>
          <p id="Par15">Next-generation sequencing</p>
        </def>
      </def-item>
      <def-item>
        <term>NLC</term>
        <def>
          <p id="Par16">Non-liver cirrhosis</p>
        </def>
      </def-item>
      <def-item>
        <term>OTU</term>
        <def>
          <p id="Par17">Operational taxonomic unit</p>
        </def>
      </def-item>
      <def-item>
        <term>PCA</term>
        <def>
          <p id="Par18">Principle components analysis</p>
        </def>
      </def-item>
      <def-item>
        <term>QAP</term>
        <def>
          <p id="Par19">Quasispecies analysis package</p>
        </def>
      </def-item>
      <def-item>
        <term>QS</term>
        <def>
          <p id="Par20">Quasispecies</p>
        </def>
      </def-item>
      <def-item>
        <term>RF</term>
        <def>
          <p id="Par21">Random forest</p>
        </def>
      </def-item>
      <def-item>
        <term>Sn</term>
        <def>
          <p id="Par22">Shannon entropy Efficiency</p>
        </def>
      </def-item>
      <def-item>
        <term>SVM</term>
        <def>
          <p id="Par23">Support vector machine</p>
        </def>
      </def-item>
      <def-item>
        <term>TGS</term>
        <def>
          <p id="Par24">Third-generation sequencing</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher’s Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
    <fn>
      <p>Mingjie Wang and Jianfeng Li contributed equally to this work.</p>
    </fn>
  </fn-group>
  <sec>
    <title>Supplementary information</title>
    <p><bold>Supplementary information</bold> accompanies this paper at 10.1186/s12864-020-6744-4.</p>
  </sec>
  <ack>
    <title>Acknowledgements</title>
    <p>We thank Prof. Chen Jun (Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic) for his valuable advice about QS quantification algorithms.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors’ contributions</title>
    <p>WMJ, LJF, HJY and ZXX designed the workflow. WMJ developed the command line tools and GUI, performed data analysis. HY, YDM, ZDH, YZT and ZXX enrolled the patients. YZT and ZXN carried out all experiments. LJF set up Galaxy framework of wQAP and built Docker image. WMJ developed tools in wQAP. WMJ and LJF designed and built QAP website. ZXX, HJY, YZT and YZH supervised and supported the whole project. WMJ, LJF, YZT, HJY and ZXX wrote and edited the manuscript. All authors read and agreed on the final version of the manuscript. All authors read and approved the final manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This work was supported by grants from the National Natural Science Foundation of China [grant numbers 81672069, 81570122, 81770205], the Shanghai Municipal International Cooperation Grant [grant number 16410711900], the Major National Projects for Infectious Diseases [grant numbers 2017ZX10202202], the National Key Research and Development Program [grant number 2016YFC0902800], Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support [grant number 20161303], the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning [grant number QD2015005], and the Shanghai Health and Family Planning Commission Grant [grant number 201640089]. These funding bodies played no role in any of the following: study design, data collection, analysis, and interpretation; manuscript writing.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>All releases and detailed documentation of QAP, web service wQAP and simulation data can be found at <ext-link ext-link-type="uri" xlink:href="http://life2cloud.com:6005/qap">http://life2cloud.com:6005/qap</ext-link>. A release version of the QAP source code can also be found at Github <ext-link ext-link-type="uri" xlink:href="https://github.com/mingjiewang/qap/">https://github.com/mingjiewang/qap/</ext-link>. Docker images are deposited at Docker hub <ext-link ext-link-type="uri" xlink:href="https://hub.docker.com/r/mingjiewang/qap/">https://hub.docker.com/r/mingjiewang/qap/</ext-link>. HBV CBS raw data have been deposited at NCBI GenBank under accession IDs KY881721 to KY882003. HBV NGS, HBV TGS, H7N9 NGS raw sequencing data have been deposited at the NCBI Sequence Read Archive (SRA) under accession IDs SRP126807, SRP128001 and SRP139718. HCV and HIV NGS data were downloaded from NCBI SRA under accession IDs SRP037575 and SRP132841.</p>
  </notes>
  <notes id="FPar1">
    <title>Ethics approval and consent to participate</title>
    <p id="Par57">Written informed consent according to the Declaration of Helsinki was obtained from each subject. The study protocol was approved by the ethics committee of Ruijin Hospital, Shanghai Jiaotong University, School of Medicine, and all methods were carried out in accordance with the approved guidelines.</p>
  </notes>
  <notes id="FPar2">
    <title>Consent for publication</title>
    <p id="Par58">Not applicable.</p>
  </notes>
  <notes id="FPar3" notes-type="COI-statement">
    <title>Competing interests</title>
    <p id="Par59">The authors declare no competing interests.</p>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Domingo</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Sabo</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Taniguchi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Weissmann</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Nucleotide sequence heterogeneity of an RNA phage population</article-title>
        <source>Cell</source>
        <year>1978</year>
        <volume>13</volume>
        <fpage>735</fpage>
        <lpage>744</lpage>
        <pub-id pub-id-type="doi">10.1016/0092-8674(78)90223-4</pub-id>
        <pub-id pub-id-type="pmid">657273</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Domingo</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Sheldon</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Perales</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Viral quasispecies evolution</article-title>
        <source>Microbiol Mol Biol Rev</source>
        <year>2012</year>
        <volume>76</volume>
        <fpage>159</fpage>
        <lpage>216</lpage>
        <pub-id pub-id-type="doi">10.1128/MMBR.05023-11</pub-id>
        <pub-id pub-id-type="pmid">22688811</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lauring</surname>
            <given-names>AS</given-names>
          </name>
          <name>
            <surname>Andino</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Quasispecies theory and the behavior of RNA viruses</article-title>
        <source>PLoS Pathog</source>
        <year>2010</year>
        <volume>6</volume>
        <fpage>e1001005</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.ppat.1001005</pub-id>
        <pub-id pub-id-type="pmid">20661479</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Miura</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Maekawa</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Takano</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Komatsu</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Tatsumi</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Asakawa</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Shindo</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Amemiya</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Nakayama</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Inoue</surname>
            <given-names>T</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Deep-sequencing analysis of the association between the quasispecies nature of the hepatitis C virus core region and disease progression</article-title>
        <source>J Virol</source>
        <year>2013</year>
        <volume>87</volume>
        <fpage>12541</fpage>
        <lpage>12551</lpage>
        <pub-id pub-id-type="doi">10.1128/JVI.00826-13</pub-id>
        <pub-id pub-id-type="pmid">23946458</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <mixed-citation publication-type="other">Wang J, Yu Y, Li G, Shen C, Meng Z, Zheng J, Jia Y, Chen S, Zhang X, Zhu M, et al. Relationship between serum HBV RNA levels and intrahepatic viral as well as histologic activity markers in entecavir-treated patients. J Hepatol. 2017. 10.1016/j.jhep.2017.08.021.</mixed-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hong</surname>
            <given-names>LZ</given-names>
          </name>
          <name>
            <surname>Hong</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Wong</surname>
            <given-names>HT</given-names>
          </name>
          <name>
            <surname>Aw</surname>
            <given-names>PP</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Wilm</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>de Sessions</surname>
            <given-names>PF</given-names>
          </name>
          <name>
            <surname>Lim</surname>
            <given-names>SG</given-names>
          </name>
          <name>
            <surname>Nagarajan</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Hibberd</surname>
            <given-names>ML</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>BAsE-Seq: a method for obtaining long viral haplotypes from short sequence reads</article-title>
        <source>Genome Biol</source>
        <year>2014</year>
        <volume>15</volume>
        <fpage>517</fpage>
        <pub-id pub-id-type="doi">10.1186/s13059-014-0517-9</pub-id>
        <pub-id pub-id-type="pmid">25406369</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zagordi</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Bhattacharya</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Eriksson</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Beerenwinkel</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>ShoRAH: estimating the genetic diversity of a mixed sample from next-generation sequencing data</article-title>
        <source>BMC Bioinformatics</source>
        <year>2011</year>
        <volume>12</volume>
        <fpage>119</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2105-12-119</pub-id>
        <pub-id pub-id-type="pmid">21521499</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Prosperi</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Salemi</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>QuRe: software for viral quasispecies reconstruction from next-generation sequencing data</article-title>
        <source>Bioinformatics</source>
        <year>2012</year>
        <volume>28</volume>
        <fpage>132</fpage>
        <lpage>133</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btr627</pub-id>
        <pub-id pub-id-type="pmid">22088846</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Prabhakaran</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rey</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Zagordi</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Beerenwinkel</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Roth</surname>
            <given-names>V</given-names>
          </name>
        </person-group>
        <article-title>HIV haplotype inference using a propagating Dirichlet process mixture model</article-title>
        <source>IEEE/ACM Trans Comput Biol Bioinform</source>
        <year>2014</year>
        <volume>11</volume>
        <fpage>182</fpage>
        <lpage>191</lpage>
        <pub-id pub-id-type="doi">10.1109/TCBB.2013.145</pub-id>
        <pub-id pub-id-type="pmid">26355517</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jayasundara</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Saeed</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Maheswararajah</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>BC</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Halgamuge</surname>
            <given-names>SK</given-names>
          </name>
        </person-group>
        <article-title>ViQuaS: an improved reconstruction pipeline for viral quasispecies spectra generated by next-generation sequencing</article-title>
        <source>Bioinformatics</source>
        <year>2015</year>
        <volume>31</volume>
        <fpage>886</fpage>
        <lpage>896</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btu754</pub-id>
        <pub-id pub-id-type="pmid">25398613</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Holzer</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Marz</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Software dedicated to virus sequence analysis "bioinformatics Goes viral"</article-title>
        <source>Adv Virus Res</source>
        <year>2017</year>
        <volume>99</volume>
        <fpage>233</fpage>
        <lpage>257</lpage>
        <pub-id pub-id-type="doi">10.1016/bs.aivir.2017.08.004</pub-id>
        <pub-id pub-id-type="pmid">29029728</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Wan</surname>
            <given-names>MB</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>XX</given-names>
          </name>
        </person-group>
        <article-title>Early changes of hepatitis B virus quasispecies during lamivudine treatment and the correlation with antiviral efficacy</article-title>
        <source>J Hepatol</source>
        <year>2009</year>
        <volume>50</volume>
        <fpage>895</fpage>
        <lpage>905</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jhep.2008.12.018</pub-id>
        <pub-id pub-id-type="pmid">19304333</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>ZT</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>SY</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Cai</surname>
            <given-names>XH</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>YF</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>JH</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Characterization of full-length genomes of hepatitis B virus Quasispecies in sera of patients at different phases of infection</article-title>
        <source>J Clin Microbiol</source>
        <year>2015</year>
        <volume>53</volume>
        <fpage>2203</fpage>
        <lpage>2214</lpage>
        <pub-id pub-id-type="doi">10.1128/JCM.00068-15</pub-id>
        <pub-id pub-id-type="pmid">25926495</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Deng</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>SY</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Gong</surname>
            <given-names>QM</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>XX</given-names>
          </name>
        </person-group>
        <article-title>Evolutionary patterns of hepatitis B virus quasispecies under different selective pressures: correlation with antiviral efficacy</article-title>
        <source>Gut</source>
        <year>2011</year>
        <volume>60</volume>
        <fpage>1269</fpage>
        <lpage>1277</lpage>
        <pub-id pub-id-type="doi">10.1136/gut.2010.226225</pub-id>
        <pub-id pub-id-type="pmid">21292683</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cheng</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Guindon</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rodrigo</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Wee</surname>
            <given-names>LY</given-names>
          </name>
          <name>
            <surname>Inoue</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Thompson</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Locarnini</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lim</surname>
            <given-names>SG</given-names>
          </name>
        </person-group>
        <article-title>Cumulative viral evolutionary changes in chronic hepatitis B virus infection precedes hepatitis B e antigen seroconversion</article-title>
        <source>Gut</source>
        <year>2013</year>
        <volume>62</volume>
        <fpage>1347</fpage>
        <lpage>1355</lpage>
        <pub-id pub-id-type="doi">10.1136/gutjnl-2012-302408</pub-id>
        <pub-id pub-id-type="pmid">23242209</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bayliss</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yuen</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Rosenberg</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Wong</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Littlejohn</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Jackson</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Gaggar</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kitrinos</surname>
            <given-names>KM</given-names>
          </name>
          <name>
            <surname>Subramanian</surname>
            <given-names>GM</given-names>
          </name>
          <name>
            <surname>Marcellin</surname>
            <given-names>P</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B</article-title>
        <source>Gut</source>
        <year>2017</year>
        <volume>66</volume>
        <fpage>2013</fpage>
        <lpage>2023</lpage>
        <pub-id pub-id-type="doi">10.1136/gutjnl-2015-309300</pub-id>
        <pub-id pub-id-type="pmid">27534671</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Baaijens</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Aabidine</surname>
            <given-names>AZE</given-names>
          </name>
          <name>
            <surname>Rivals</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Schonhuth</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>De novo assembly of viral quasispecies using overlap graphs</article-title>
        <source>Genome Res</source>
        <year>2017</year>
        <volume>27</volume>
        <fpage>835</fpage>
        <lpage>848</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.215038.116</pub-id>
        <pub-id pub-id-type="pmid">28396522</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Larkin</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Blackshields</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>NP</given-names>
          </name>
          <name>
            <surname>Chenna</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>McGettigan</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>McWilliam</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Valentin</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Wallace</surname>
            <given-names>IM</given-names>
          </name>
          <name>
            <surname>Wilm</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lopez</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Clustal W and Clustal X version 2.0</article-title>
        <source>Bioinformatics</source>
        <year>2007</year>
        <volume>23</volume>
        <fpage>2947</fpage>
        <lpage>2948</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btm404</pub-id>
        <pub-id pub-id-type="pmid">17846036</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Edgar</surname>
            <given-names>RC</given-names>
          </name>
        </person-group>
        <article-title>MUSCLE: multiple sequence alignment with high accuracy and high throughput</article-title>
        <source>Nucleic Acids Res</source>
        <year>2004</year>
        <volume>32</volume>
        <fpage>1792</fpage>
        <lpage>1797</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkh340</pub-id>
        <pub-id pub-id-type="pmid">15034147</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sievers</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Higgins</surname>
            <given-names>DG</given-names>
          </name>
        </person-group>
        <article-title>Clustal omega, accurate alignment of very large numbers of sequences</article-title>
        <source>Methods Mol Biol</source>
        <year>2014</year>
        <volume>1079</volume>
        <fpage>105</fpage>
        <lpage>116</lpage>
        <pub-id pub-id-type="doi">10.1007/978-1-62703-646-7_6</pub-id>
        <pub-id pub-id-type="pmid">24170397</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Domingo</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Martin</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Perales</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Grande-Perez</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Garcia-Arriaza</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Arias</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Viruses as quasispecies: biological implications</article-title>
        <source>Curr Top Microbiol Immunol</source>
        <year>2006</year>
        <volume>299</volume>
        <fpage>51</fpage>
        <lpage>82</lpage>
        <?supplied-pmid 16568896?>
        <pub-id pub-id-type="pmid">16568896</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McKenna</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hanna</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Banks</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Sivachenko</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Cibulskis</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kernytsky</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Garimella</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Altshuler</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Gabriel</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Daly</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>DePristo</surname>
            <given-names>MA</given-names>
          </name>
        </person-group>
        <article-title>The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data</article-title>
        <source>Genome Res</source>
        <year>2010</year>
        <volume>20</volume>
        <fpage>1297</fpage>
        <lpage>1303</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.107524.110</pub-id>
        <pub-id pub-id-type="pmid">20644199</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Koboldt</surname>
            <given-names>DC</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Larson</surname>
            <given-names>DE</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>McLellan</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Miller</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Mardis</surname>
            <given-names>ER</given-names>
          </name>
          <name>
            <surname>Ding</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>RK</given-names>
          </name>
        </person-group>
        <article-title>VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing</article-title>
        <source>Genome Res</source>
        <year>2012</year>
        <volume>22</volume>
        <fpage>568</fpage>
        <lpage>576</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.129684.111</pub-id>
        <pub-id pub-id-type="pmid">22300766</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wilm</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Aw</surname>
            <given-names>PP</given-names>
          </name>
          <name>
            <surname>Bertrand</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Yeo</surname>
            <given-names>GH</given-names>
          </name>
          <name>
            <surname>Ong</surname>
            <given-names>SH</given-names>
          </name>
          <name>
            <surname>Wong</surname>
            <given-names>CH</given-names>
          </name>
          <name>
            <surname>Khor</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Petric</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Hibberd</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Nagarajan</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets</article-title>
        <source>Nucleic Acids Res</source>
        <year>2012</year>
        <volume>40</volume>
        <fpage>11189</fpage>
        <lpage>11201</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gks918</pub-id>
        <pub-id pub-id-type="pmid">23066108</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tuteja</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Siddiqui</surname>
            <given-names>AB</given-names>
          </name>
          <name>
            <surname>Madan</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Goyal</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Shalimar</surname>
          </name>
          <name>
            <surname>Sreenivas</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Kaur</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Panda</surname>
            <given-names>SK</given-names>
          </name>
          <name>
            <surname>Narayanasamy</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Subodh</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Acharya</surname>
            <given-names>SK</given-names>
          </name>
        </person-group>
        <article-title>Mutation profiling of the hepatitis B virus strains circulating in North Indian population</article-title>
        <source>PLoS One</source>
        <year>2014</year>
        <volume>9</volume>
        <fpage>e91150</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0091150</pub-id>
        <pub-id pub-id-type="pmid">24637457</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Crooks</surname>
            <given-names>GE</given-names>
          </name>
          <name>
            <surname>Hon</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Chandonia</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Brenner</surname>
            <given-names>SE</given-names>
          </name>
        </person-group>
        <article-title>WebLogo: a sequence logo generator</article-title>
        <source>Genome Res</source>
        <year>2004</year>
        <volume>14</volume>
        <fpage>1188</fpage>
        <lpage>1190</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.849004</pub-id>
        <pub-id pub-id-type="pmid">15173120</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Afgan</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Baker</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>van den Beek</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Blankenberg</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Bouvier</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Cech</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Chilton</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Clements</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Coraor</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Eberhard</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update</article-title>
        <source>Nucleic Acids Res</source>
        <year>2016</year>
        <volume>44</volume>
        <fpage>W3</fpage>
        <lpage>w10</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkw343</pub-id>
        <pub-id pub-id-type="pmid">27137889</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>F</given-names>
          </name>
        </person-group>
        <article-title>A comparative study on the characterization of hepatitis B virus quasispecies by clone-based sequencing and third-generation sequencing</article-title>
        <source>Emerg Microbes Infect</source>
        <year>2017</year>
        <volume>6</volume>
        <fpage>e100</fpage>
        <?supplied-pmid 29116219?>
        <pub-id pub-id-type="pmid">29116219</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gong</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Hao</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Sheng</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>XH</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Gong</surname>
            <given-names>QM</given-names>
          </name>
          <name>
            <surname>Tian</surname>
            <given-names>F</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Comparison of next-generation sequencing and clone-based sequencing in analysis of hepatitis B virus reverse transcriptase quasispecies heterogeneity</article-title>
        <source>J Clin Microbiol</source>
        <year>2013</year>
        <volume>51</volume>
        <fpage>4087</fpage>
        <lpage>4094</lpage>
        <pub-id pub-id-type="doi">10.1128/JCM.01723-13</pub-id>
        <pub-id pub-id-type="pmid">24088859</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Babcock</surname>
            <given-names>GJ</given-names>
          </name>
          <name>
            <surname>Iyer</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>HL</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Rowley</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Ambrosino</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Zamore</surname>
            <given-names>PD</given-names>
          </name>
          <name>
            <surname>Pierce</surname>
            <given-names>BG</given-names>
          </name>
          <name>
            <surname>Molrine</surname>
            <given-names>DC</given-names>
          </name>
          <name>
            <surname>Weng</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>High-throughput sequencing analysis of post-liver transplantation HCV E2 glycoprotein evolution in the presence and absence of neutralizing monoclonal antibody</article-title>
        <source>PLoS One</source>
        <year>2014</year>
        <volume>9</volume>
        <fpage>e100325</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0100325</pub-id>
        <pub-id pub-id-type="pmid">24956119</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yen</surname>
            <given-names>HL</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Tian</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Guan</surname>
            <given-names>W</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Drug susceptibility profile and pathogenicity of H7N9 influenza virus (Anhui1 lineage) with R292K substitution</article-title>
        <source>Emerg Microbes Infect</source>
        <year>2014</year>
        <volume>3</volume>
        <fpage>e78</fpage>
        <?supplied-pmid 26038501?>
        <pub-id pub-id-type="pmid">26038501</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Hao</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Yen</surname>
            <given-names>HL</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>T</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Association between adverse clinical outcome in human disease caused by novel influenza a H7N9 virus and sustained viral shedding and emergence of antiviral resistance</article-title>
        <source>Lancet</source>
        <year>2013</year>
        <volume>381</volume>
        <fpage>2273</fpage>
        <lpage>2279</lpage>
        <pub-id pub-id-type="doi">10.1016/S0140-6736(13)61125-3</pub-id>
        <pub-id pub-id-type="pmid">23726392</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Leviyang</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Griva</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Ita</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>WE</given-names>
          </name>
        </person-group>
        <article-title>A penalized regression approach to haplotype reconstruction of viral populations arising in early HIV/SIV infection</article-title>
        <source>Bioinformatics</source>
        <year>2017</year>
        <volume>33</volume>
        <fpage>2455</fpage>
        <lpage>2463</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btx187</pub-id>
        <pub-id pub-id-type="pmid">28379346</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xue</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>ZT</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>DH</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>XX</given-names>
          </name>
        </person-group>
        <article-title>Clinical features and viral quasispecies characteristics associated with infection by the hepatitis B virus G145R immune escape mutant</article-title>
        <source>Emerg Microbes Infect</source>
        <year>2017</year>
        <volume>6</volume>
        <fpage>e15</fpage>
        <pub-id pub-id-type="doi">10.1038/emi.2017.2</pub-id>
        <pub-id pub-id-type="pmid">28325923</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bull</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Eltahla</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Rodrigo</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Koekkoek</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Walker</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pirozyan</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Betz-Stablein</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Toepfer</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Laird</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Oh</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A method for near full-length amplification and sequencing for six hepatitis C virus genotypes</article-title>
        <source>BMC Genomics</source>
        <year>2016</year>
        <volume>17</volume>
        <fpage>247</fpage>
        <pub-id pub-id-type="doi">10.1186/s12864-016-2575-8</pub-id>
        <pub-id pub-id-type="pmid">26988550</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
